Skip to main content
Medical information Clinical review pending

Cytogenetics

Oncopro Lung Basic Panel Test

The Oncopro Lung Basic Panel Test helps diagnose and characterize lung tumors, aiding oncologists in treatment decisions. It analyzes key genetic markers like ALK1, ROS1, and EGFR.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Paraffin block containing tumor tissue.
Results
Confirm with the laboratory before booking.
Preparation
The paraffin block must contain at least 10% tumor cells. A duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory. Confirm with the laboratory before booking.
Test priceKSh 28,080

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Oncopro Lung Basic Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Diagnosis of lung cancer
  • ✓Characterization of lung tumor genetics
  • ✓Guiding targeted therapy selection
  • ✓Patients with symptoms suggestive of lung cancer
  • ✓Patients with known lung tumors
  • ✓Individuals with risk factors for lung cancer
02

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in lung tumors (ALK1, ROS1, EGFR) that can guide targeted cancer therapy and improve treatment outcomes.
The Oncopro Lung Basic Panel Test is a specialized diagnostic tool designed to aid in the detection and characterization of lung tumors. As lung cancer remains one of the most prevalent forms of cancer worldwide, early and accurate diagnosis is crucial for effective treatment and management. This test helps oncologists make informed decisions regarding patient care, ensuring that individuals receive the most appropriate therapies based on their unique tumor profiles.

The test evaluates several critical components essential for understanding lung cancer, including ALK1-FISH, ROS1-FISH, and EGFR Mutation Analysis. These analyses detect specific genetic alterations that can influence treatment options and prognosis.

Individuals who exhibit symptoms or have risk factors associated with lung cancer should consider this test. Symptoms may include a persistent cough, chest pain, unexplained weight loss, or shortness of breath. Those with a family history of lung cancer or other risk factors, such as smoking, should also consult with their healthcare provider.

Taking this test offers benefits such as early detection, personalized treatment options based on genetic mutations, and valuable information for patient care. Results will be available within the specified turnaround time and should be discussed with your oncologist to understand their implications and determine the best course of action.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationThe paraffin block must contain at least 10% tumor cells. A duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory. Confirm with the laboratory before booking.
SampleParaffin block containing tumor tissue.
MethodologyFISH (Fluorescence In Situ Hybridization) for ALK1 and ROS1; Sanger Sequencing for EGFR Mutation Analysis.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Test results are based on the provided sample. The presence or absence of specific mutations does not guarantee treatment response or prognosis. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test analyzes specific genetic markers (ALK1, ROS1, EGFR) in lung tumor tissue to help diagnose lung cancer and guide treatment decisions.
Individuals with symptoms suggestive of lung cancer, those diagnosed with lung cancer, or individuals with significant risk factors should discuss this test with their doctor.
A paraffin block containing tumor tissue is required for this test. The block must contain at least 10% tumor cells.
Turnaround time varies. Please confirm the current turnaround time with the laboratory before booking.
The test measures alterations in the ALK1 and ROS1 genes using FISH, and mutations in the EGFR gene using Sanger Sequencing.
You can book the test by calling or WhatsApping +254711564616. We have branches in major cities and offer home sample collection.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp